Form 4 filed by van Houte Hans
van Houte Hans filed this Form 4 on NRIX (Nurix Therapeutics, Inc.) with 7 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 00:47:02 UTC.
- Accession
- 0001817217-26-000014
- Filer
- CIK 1817217
- Filed
- 2026-11-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: NRIX · Nurix Therapeutics, Inc. (CIK 1549595)
- van Houte Hans officer (Chief Financial Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-30 | M exercised | +3,750 | $0 | 43,916 | D |
| Common Stock | 2026-10-30 | M exercised | +2,859 | $0 | 46,775 | D |
| Common Stock | 2026-10-30 | M exercised | +3,573 | $0 | 50,348 | D |
| Common Stock | 2026-10-30 | S sold | -2,834 | $26.2791 | 47,514 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -3,750 | $0 | 7,500 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -2,859 | $0 | 17,150 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -3,573 | $0 | 35,730 | D |